You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY21 is not expected to be complete until September, 2022.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. STTR Phase I: Advanced Microfluidic Devices for Point-of-Care COVID-19 Serological Testing

    SBC: Access Sensor Technologies LLC            Topic: BM

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project may reach millions of people and provide a key tool in safeguarding the public health through the COVID-19 pandemic. Sensitive, selective and quantitative detection usually requires complex laboratory-based methods and instrumentation to achieve consistent results; however, this project advanc ...

    STTR Phase I 2020 National Science Foundation
  2. STTR Phase I: COVID-19- High-Brightness Fluorescent Probes for Quantitative Polymerase Chain Reaction

    SBC: StabiLux Biosciences, Inc            Topic: BT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to develop a new probe to detect low levels of viral load, such as that causing COVID-19. Rapid and reliable kits are not currently readily available. This project will provide rapid detection of viral material using exsiting cost-effective techniques with fewer detection errors. Being able ...

    STTR Phase I 2020 National Science Foundation
  3. STTR Phase I: Active Transport of Caffeine through a Blood-Brain Barrier Model

    SBC: Nistron, L.L.C.            Topic: BT

    The broader impact of this Small Business Technology Transfer (STTR) Phase I project is to create a drug-discovery platform that will screen quickly and early in the process for candidate therapeutics that can enter the central nervous system (CNS). The goal is to minimize the lengthy and expensive clinical trials that ultimately fail because of their failure to enter the BBB by providing a high a ...

    STTR Phase I 2020 National Science Foundation
  4. STTR Phase I: Remote patient monitoring of medication fall risk in the elderly

    SBC: SUMAQ LIFE LLC            Topic: MD

    The broader impact/commerical potential of this Small Business Innovation Research (SBIR) Phase I project will be a potentially significant reduction in medication-related falls, injuries, and deaths, as well as a reduction in fall-related medical costs. The number of older adults dying from falls increased by a factor of three between 2000 and 2016, with increased medication use possibly contribu ...

    STTR Phase I 2020 National Science Foundation
  5. STTR Phase I: AI-assisted Assessment, Tracking, and Reporting of COVID-19 Severity on Chest CT

    SBC: AI METRICS, LLC            Topic: DH

    The broader impact /commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to leverage artificial intelligence (AI) to reduce errors and improve accuracy, standardization, agreement, and reporting in evaluation of COVID-19 lung disease severity on chest computed tomography (CT) images. Chest CT procedures play a critical role in COVID-19 patients but current meth ...

    STTR Phase I 2020 National Science Foundation
  6. STTR Phase I: Computerized System for Detection, Assessment, and Visualization of Intraoperative Bleeding During Robotic and Laparoscopic Surgery

    SBC: REDIMINDS, INC.            Topic: R

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to reduce the morbidity and mortality of patients undergoing surgery. Inadvertent bleeding during surgery represents a critical problem that occurs during all types of procedures on millions of patients around the world. This project will advance a robotic surgical tool system using artific ...

    STTR Phase I 2020 National Science Foundation
  7. STTR Phase I: Enabling Rapid Scale-up of COVID-19 Treatment using Next-Generation Light Driven Chemistry

    SBC: New Iridium Inc            Topic: CT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) project is to develop a photocatalytic process to facilitate enhanced speed and efficiency for production of key intermediate chemicals for production of Remdesivir, a potential life-saving drug in the fight against COVID-19. Remdesivir has been identified as one of the most promising treatments for COVID-19; ...

    STTR Phase I 2020 National Science Foundation
  8. STTR Phase I: Lightweight Concrete Interlocking Masonry Blocks

    SBC: CLC Global-USA            Topic: AM

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to improve job-site safety of dry-stacking installation of masonry walls without binding mortar through the use of novel Aerated Interlocking Masonry Units (AIMU). The AIMU multi-component wall system combines the advantages of wood and those of concrete and is potentially applicable for mi ...

    STTR Phase I 2020 National Science Foundation
  9. STTR Phase I: A Fully-Automated Endoscopic Scoring System for Ulcerative Colitis

    SBC: PREHAB TECHNOLOGIES, LLC            Topic: BM

    The broader/commercial impact of this STTR Phase 1 project will develop an automated system that significantly increases the speed, reliability, and accuracy of disease severity assessment in ulcerative colitis (UC) patients. This lifelong debilitating disease impacts almost 1 M US patients, and developing effective treatments requires accurate, reliable, and timely scoring. Currently, the FDA-app ...

    STTR Phase I 2020 National Science Foundation
  10. Circulating Diagnostic Markers of Infectious Disease

    SBC: PATHOVACS INCORPORATED            Topic: CBD18A001

    Assays for accurate diagnosis of early stages of infection with biothreat agents, on the day of infection or within a few days of infection, will find wide use in both civilian and military applications These diagnostic assays, which are anticipated to be highly specific and sensitive, will add to the repertoire of tools of hospitals and clinics that serve our armed forces personnel deployed on th ...

    STTR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense
US Flag An Official Website of the United States Government